» Download Public Reports
25 reports
- Company report
- June 2011
- 10 pages
... Compared with 18.6 Million euros in the six-month period ended june 30, 2010. This increase was due principally to the increase in expenses relating to clinical trials as well as to increased r ...
April 2011
... February: termination by roche of the 2007 licensing agreement re: tg4001. March: completion of the recruitment of patients in the hcvac study, a phase ii clinical trial with tg4040 in type c hepatitis ...
March 2011
... Year, as scheduled. An expansion to 4 additional new european countries is ongoing for the phase ii clinical trial with validive , Developed in the treatment of severe radio- and chemotherapy ...
April 2013
... Health will drive forward public health knowledge, which is a key issue for all governments." The french-german advanced translational drug discovery center is a unique project of public- private ...
October 2012
... Citoxlab group announces a 34 per cent revenue increase for the first half of 2012 one year after merger of france-based pre-clinical research organization, cit, and canada S lab ...
June 2012
... Genfit is a biopharmaceutical company focused on the discovery and development of drug cands in therapeutic fields linked to cardiometabolic disorders (prediabetes/diabetes, atherosclerosis ...
April 2012
... For outsourcing of drug discovery and development to smaller biotechnology companies by large global pharmaceutical companies due to factors such as reduced r&d productivity, expected patent cliff during ...
March 2011
... Product can appear to be promising at a development stage or after clinical trials but never be launched on the market or be launched on the market but fail to sell notably for regulatory or competitive ...
November 2011
... Preparing and achieving the report of a clinical trial data assembling intention to treat analysis according to the protocol groups Comparability sub-group analysis interpretation of the clinical ...